<code id='AB6EAA57B6'></code><style id='AB6EAA57B6'></style>
    • <acronym id='AB6EAA57B6'></acronym>
      <center id='AB6EAA57B6'><center id='AB6EAA57B6'><tfoot id='AB6EAA57B6'></tfoot></center><abbr id='AB6EAA57B6'><dir id='AB6EAA57B6'><tfoot id='AB6EAA57B6'></tfoot><noframes id='AB6EAA57B6'>

    • <optgroup id='AB6EAA57B6'><strike id='AB6EAA57B6'><sup id='AB6EAA57B6'></sup></strike><code id='AB6EAA57B6'></code></optgroup>
        1. <b id='AB6EAA57B6'><label id='AB6EAA57B6'><select id='AB6EAA57B6'><dt id='AB6EAA57B6'><span id='AB6EAA57B6'></span></dt></select></label></b><u id='AB6EAA57B6'></u>
          <i id='AB6EAA57B6'><strike id='AB6EAA57B6'><tt id='AB6EAA57B6'><pre id='AB6EAA57B6'></pre></tt></strike></i>

          Home / hotspot / leisure time

          leisure time


          leisure time

          author:leisure time    Page View:29611
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In